JAMP-PAROXETINE DIN 02368870
Status: Dormant
Holder: JAMP PHARMA CORPORATION
Available to quote
Health Canada record
| Active ingredient(s) | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 20 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N06AB05 PAROXETINE |
| Original market date | 24-Oct-2011 |
| Current status date | 03-Aug-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Jamp Pharma Corporation — licence 100590, currently licensed, last inspection rating C (2025-01-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02383276 | AURO-PAROXETINE | AURO PHARMA INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 10 MG | Marketed |
| 02383292 | AURO-PAROXETINE | AURO PHARMA INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 30 MG | Marketed |
| 02383284 | AURO-PAROXETINE | AURO PHARMA INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 20 MG | Marketed |
| 02444909 | BIO-PAROXETINE | BIOMED PHARMA | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 10 MG | Marketed |
| 02444925 | BIO-PAROXETINE | BIOMED PHARMA | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 30 MG | Marketed |
| 02444917 | BIO-PAROXETINE | BIOMED PHARMA | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 20 MG | Marketed |
| 02410834 | IPG-PAROXETINE | MARCAN PHARMACEUTICALS INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 10 MG | Approved |
| 02410850 | IPG-PAROXETINE | MARCAN PHARMACEUTICALS INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 30 MG | Approved |
| 02410842 | IPG-PAROXETINE | MARCAN PHARMACEUTICALS INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 20 MG | Approved |
| 02467402 | M-PAROXETINE | MANTRA PHARMA INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 10 MG | Marketed |
| 02467410 | M-PAROXETINE | MANTRA PHARMA INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 20 MG | Marketed |
| 02467429 | M-PAROXETINE | MANTRA PHARMA INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 30 MG | Marketed |
| 02411946 | MAR-PAROXETINE | MARCAN PHARMACEUTICALS INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 10 MG | Marketed |
| 02411962 | MAR-PAROXETINE | MARCAN PHARMACEUTICALS INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 30 MG | Marketed |
| 02411954 | MAR-PAROXETINE | MARCAN PHARMACEUTICALS INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 20 MG | Marketed |
| 02421372 | MINT-PAROXETINE | MINT PHARMACEUTICALS INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 10 MG | Marketed |
| 02421399 | MINT-PAROXETINE | MINT PHARMACEUTICALS INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 30 MG | Marketed |
| 02421380 | MINT-PAROXETINE | MINT PHARMACEUTICALS INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 20 MG | Marketed |
| 02479788 | NRA-PAROXETINE | NORA PHARMA INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 30 MG | Marketed |
| 02479753 | NRA-PAROXETINE | NORA PHARMA INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 10 MG | Marketed |
| 02479761 | NRA-PAROXETINE | NORA PHARMA INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 20 MG | Marketed |
| 02477858 | PAROXETINE | ALTAMED PHARMA | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 30 MG | Marketed |
| 02477831 | PAROXETINE | ALTAMED PHARMA | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 20 MG | Marketed |
| 02477823 | PAROXETINE | ALTAMED PHARMA | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 10 MG | Marketed |
| 02282860 | PAROXETINE | SANIS HEALTH INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 30 MG | Marketed |
| 02282852 | PAROXETINE | SANIS HEALTH INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 20 MG | Marketed |
| 02282844 | PAROXETINE | SANIS HEALTH INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 10 MG | Marketed |
| 02248560 | RIVA-PAROXETINE | LABORATOIRE RIVA INC. | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 20 MG | Marketed |
| 02248561 | RIVA-PAROXETINE | LABORATOIRE RIVA INC. | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 30 MG | Marketed |
| 02248559 | RIVA-PAROXETINE | LABORATOIRE RIVA INC. | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 10 MG | Marketed |
| 02475545 | AG-PAROXETINE | ANGITA PHARMA INC. | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 20 MG | Dormant |
| 02475553 | AG-PAROXETINE | ANGITA PHARMA INC. | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 30 MG | Dormant |
| 02475537 | AG-PAROXETINE | ANGITA PHARMA INC. | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 10 MG | Dormant |
| 02368862 | JAMP-PAROXETINE | JAMP PHARMA CORPORATION | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 10 MG | Dormant |
| 02368889 | JAMP-PAROXETINE | JAMP PHARMA CORPORATION | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 30 MG | Dormant |
| 02444313 | PRIVA-PAROXETINE | PHARMAPAR INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 10 MG | Cancelled Post Market |
| 02444348 | PRIVA-PAROXETINE | PHARMAPAR INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 30 MG | Cancelled Post Market |
| 02444321 | PRIVA-PAROXETINE | PHARMAPAR INC | Tablet | PAROXETINE (PAROXETINE HYDROCHLORIDE HEMIHYDRATE) 20 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 17674 | 2016-01-18 | Abbreviated New Drug Submission (ANDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |
| 12531 | 2011-08-02 | Abbreviated New Drug Submission (ANDS) | New Manufacturer and PRoduct Name |